163 related articles for article (PubMed ID: 18058225)
21. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Merajver SD; Schwartz K
Breast J; 2014; 20(2):185-91. PubMed ID: 24372839
[TBL] [Abstract][Full Text] [Related]
22. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.
van Golen KL; Bao L; DiVito MM; Wu Z; Prendergast GC; Merajver SD
Mol Cancer Ther; 2002 Jun; 1(8):575-83. PubMed ID: 12479217
[TBL] [Abstract][Full Text] [Related]
23. RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells.
Wynn ML; Yates JA; Evans CR; Van Wassenhove LD; Wu ZF; Bridges S; Bao L; Fournier C; Ashrafzadeh S; Merrins MJ; Satin LS; Schnell S; Burant CF; Merajver SD
J Biol Chem; 2016 Jun; 291(26):13715-29. PubMed ID: 27129239
[TBL] [Abstract][Full Text] [Related]
24. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase.
Lehman HL; Van Laere SJ; van Golen CM; Vermeulen PB; Dirix LY; van Golen KL
Mol Cancer Res; 2012 Oct; 10(10):1306-18. PubMed ID: 22896661
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
26. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
van Golen KL; Davies S; Wu ZF; Wang Y; Bucana CD; Root H; Chandrasekharappa S; Strawderman M; Ethier SP; Merajver SD
Clin Cancer Res; 1999 Sep; 5(9):2511-9. PubMed ID: 10499627
[TBL] [Abstract][Full Text] [Related]
27. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory breast cancer: Epidemiologic data and therapeutic results.
Boussen H; Berrazaga Y; Sherif Kullab ; Manai M; Berrada N; Mejri N; Siala I; Levine PH; Cristofanilli M
Int Rev Cell Mol Biol; 2024; 384():1-23. PubMed ID: 38637094
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
Sawaki M; Ito Y; Akiyama F; Tokudome N; Horii R; Mizunuma N; Takahashi S; Horikoshi N; Imai T; Nakao A; Kasumi F; Sakamoto G; Hatake K
Breast Cancer; 2006; 13(2):172-8. PubMed ID: 16755113
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Bastawisy AE; Yehia M; Gadalla SM; Swain SM; Merajver SD; Brown LM; Pfeiffer RM; Soliman AS
Breast Cancer Res Treat; 2020 Nov; 184(2):543-558. PubMed ID: 32876910
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
[TBL] [Abstract][Full Text] [Related]
32. Radiation for inflammatory breast cancer: Updates.
Stauder MC
Int Rev Cell Mol Biol; 2024; 384():25-46. PubMed ID: 38637098
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.
Faldoni FLC; Rainho CA; Rogatto SR
Cells; 2020 May; 9(5):. PubMed ID: 32397183
[TBL] [Abstract][Full Text] [Related]
34. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
Abraham HG; Xia Y; Mukherjee B; Merajver SD
Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
[TBL] [Abstract][Full Text] [Related]
35. Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy.
Wu M; Merajver SD
Breast Dis; 2005-2006; 22():25-34. PubMed ID: 16735784
[TBL] [Abstract][Full Text] [Related]
36. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S; Van der Auwera I; Van den Eynden GG; Fox SB; Bianchi F; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2005 Oct; 93(3):237-46. PubMed ID: 16172796
[TBL] [Abstract][Full Text] [Related]
37. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
38. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.
Levine PH; Steinhorn SC; Ries LG; Aron JL
J Natl Cancer Inst; 1985 Feb; 74(2):291-7. PubMed ID: 3856043
[TBL] [Abstract][Full Text] [Related]
40. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere S; Colpaert CG; van Dam P; Merajver S; Kleer CG; Harris AL; Van Marck EA; Dirix LY; Vermeulen PB
Breast Cancer Res Treat; 2004 May; 85(1):13-22. PubMed ID: 15039594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
